Skip to main content

Study M1129

Study name

An ZW 2023

Title

Hippocampal proteomics reveals the role of glutamatergic synapse activation in the depression induced by perfluorooctane sulfonate

Overall design

The aim of this study was to examine the effect of perfluorooctane sulfonate exposure on depression in adult mice. Male C57BL/6J mice were divided into the following 3 groups (n = 8 in each group): (1) control group (vehicle treatment), (2) middle dose of perfluorooctane sulfonate group (perfluorooctane sulfonate treatment at the dose of 1.0 mg/kg), and (3) high dose of perfluorooctane sulfonate group (perfluorooctane sulfonate treatment at the dose of 3.0 mg/kg). The mice were administered various concentrations of perfluorooctane sulfonate orally for 12 weeks. The results of behavior tests showed that perfluorooctane sulfonate exposure led to depressive-like behaviors in male mice. Neurotransmitters and amino acid levels in the hippocampus were determined by LC-MS/MS (n = 5 per group).

Study Type

Type1;

Data available

Unavailable

Organism

Mouse; C57BL/6J mouse;

Categories of depression

Animal model; Other animal model; Other animal model;

Criteria for depression

Forced swimming test, tail suspension test

Sample size

15

Tissue

Central; Brain; Hippocampus;

Platform

MS-based; LC-MS: AB SCIEX Triple Quad TM 4500MD;

PMID

37191230

DOI

10.1021/acs.jafc.3c01344

Citation

An Z, Yang J, Xiao F, et al. Hippocampal proteomics reveals the role of glutamatergic synapse activation in the depression induced by perfluorooctane sulfonate. J Agric Food Chem. 2023 May 24;71(20):7866-7877.

Metabolite

L-Tryptophan;

L-Proline;

L-Glutamic acid;

L-Glutamine;

Glutamine/Glutamate ratio;